Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones

Yale Journal of Biology and Medicine

Volumn 71, Issue 3-4, 1999, Pages 337-346

  Beinborn, Martin ^a   Chen, C ^a   DeMeo, L ^a   McBride, E W ^a   Kopin, A S ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; BENZODIAZEPINE DERIVATIVE; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; GASTRIN RECEPTOR; INOSITOL PHOSPHATE; LIGAND; PD 135158; PEPTIDE HORMONE;

ANIMAL CELL; CELL FUNCTION; CELL PROLIFERATION; CONFERENCE PAPER; ENTEROCHROMAFFIN CELL; HORMONAL REGULATION; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANIMALS; BENZODIAZEPINES; BENZODIAZEPINONES; CALCIUM; COS CELLS; DEVAZEPIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HORMONE ANTAGONISTS; HUMANS; INDOLES; INOSITOL PHOSPHATES; LIGANDS; MEGLUMINE; MOLECULAR MIMICRY; PEPTOIDS; PHENETHYLAMINES; PHENYLUREA COMPOUNDS; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; RECOMBINANT PROTEINS;

EID: 0032865097     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Lee, Y.-M., Beinborn, M., McBride, E.W., Lu, M., Kolakowski, L.F., Jr., and Kopin, A.S. The human brain cholecystokinin-B/gastrin receptor - Cloning and characterization. J. Biol. Chem. 268:8164-8169, 1993.
2. Wank, S.A. Cholecystokinin receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 269:G628-G646, 1995.
3. Chuang, C.-N., Chen, C.V., and Soll, A.H. Gastrin receptors regulating acid secretory function and growth. In: Walsh, J.H., ed. Gastrin. New York: Raven Press; 1993, p. 139-150.
4. Walsh, J.H. Gastrin. In: Walsh, J.H. and Dockray, G.J. Gut Peptides. New York: Raven Press; 1994, pp. 75-121.
5. Modlin, I.M. and Tang, L.H. The gastric enterochromaffin-like cell: An enigmatic cellular link. Gastroenterology 111:783-810, 1996.
6. Dourish, C.T., O'Neill, M.F., Coughlan, J. Kitchener, S.J., Hawley, D., and Iversen, S.D., The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur. J. Pharmacol. 176:35-44, 1990.
7. Ravard, S. and Dourish, C.T. Cholecystokinin and anxiety. Trends Pharmacol. Sci. 11:271-273, 1990.
8. Singh, L., Lewis, A.S., Field, M.J., Hughes, J., and Woodruff, G.N. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc. Natl. Acad. Sci. USA 88:1130-1133, 1991.
9. Wiertelak, E.P., Maier, S.F., and Watkins, L.R. Cholecystokinin antialgesia: safety cues abolish morphine analgesia. Science 256:830-833, 1992.
10. Blommaert, A.G.S., Weng, J.H., Dorville, A., McCort, I. Ducos, B., Durieux, C., and Roques, B.P. Cholecystokinin peptidomimetics as selective CCK-B antagonists - design, synthesis, and in vitro and in vivo biochemical properties. J. Med. Chem. 36:2868-2877, 1993.
11. Horwell, D.C. Development of CCK-B antagonists. Neuropeptides 19(suppl):57-64, 1991.
12. Jensen, R.T., Huang, S.C., von Schrenck, T., Wank, S.A., and Gardner, J.D. Cholecystokinin receptor antagonists: ability to distinguish various classes of cholecystokinin receptors. In: Thompson, J.C., ed. Gastrointestinal Endocrinology: Receptors and Post-receptor Mechanisms. San Diego, CA: Harcourt Brace Jovanovich; 1990, p. 95-113.
13. Wettstein, J.G., Buéno, L., and Junien, J.L. CCK antagonists: pharmacology and therapeutic interest. Pharmacol. Ther. 62:267-282, 1994.
14. Kopin, A.S., McBride, E.W., Quinn, S.M., Kolakowski, L.F., Jr., and Beinborn, M. The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands. J. Biol. Chem. 270:5019-5023, 1995.
15. Watson, S. and Arkinstall, S. The G-protein linked receptor facts book. San Diego: Academic Press, 1994.
16. Ding, X.Q., Chen, D., and Håkanson, R. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase. Gastroenterology 109:1181-1187, 1995.
17. Schmassmann, A., Garner, A., Flogerzi, B., Hasan, M.Y., Sanner, M., Varga, L., and Halter, F. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat. Gut 35:270-274, 1994.
18. B antagonists using a functional assay in the rat central nervous system. Br. J. Pharmacol. 112:666-670, 1994.
19. Eissele, R., Koop, H., Bothe-Sandfort, E., and Arnold, R. Effect of gastrin receptor antagonists on gastric acid secretion and gastrin and somatostatin release in the rat. Digestion 53:179-188, 1992.
20. Eissele, R., Patberg, H., Koop, H., Krack, W., Lorenz, W., McKnight, A.T., and Arnold, R. Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria. Gastroenterology 103:1596-1601, 1992.
21. B/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat. Br. J. Pharmacol. 104:973-977, 1991.
22. 2+ channels in HIT cells. Second-messenger synarchy in beta-cells. Diabetes 38:874-880, 1989.
23. i in secretagogue-stimulated rabbit gastric mucous cells. Am. J. Physiol. Gastrointest. Liver Physiol. 260:G133-G141, 1991.
24. 2+ and elevation of inositol triphosphate by secretagogues in parietal and chief cells isolated from rabbit gastric mucosa. Biochim. Biophys. Acta Mol. Cell Res. 888:116-125, 1986.
25. 2+ in isolated parietal cells. Differential effects of secretagogues. Biochem. Biophys. Acta 805:181-186, 1984.
26. Roche, S., BaLi, J.P., and Magous, R. Involvement of a pertussis toxin-sensitive G protein in the action of gastrin on gastric parietal cells. Biochim. Biophys. Acta 1055:287-294, 1990.
27. Horwell, D.C., Hughes, J., Hunter, J.C., Pritchard, M.C., Richardson, R.S., Roberts, E., and Woodruff, G.N. Rationally designed "dipeptoid" analogues of CCK. α-methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties. J. Med. Chem. 34:404-414, 1991.
28. Hughes, J., Boden, P., Costall, B., Domeney, A., Kelly, E., Horwell, D.C., Hunter, J.C., Pinnock, R.D., and Woodruff, G.N. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. USA 87:6728-6732, 1990.
29. Chang, R.S.L. and Lotti, V.. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc. Natl. Acad. Sci. USA 83:4923-4926, 1986.
30. Lotti, V.J. and Chang, R.S.L. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur. J. Pharmacol. 162:273-280, 1989.
31. Nishida, A., Miyata, K., Tsutsumi, R., Yuki, H., Akuzawa, S., Kobayashi, A., Kamato, T., Ito, H., Yamano, M., Katuyama, Y., Satoh, M., Ohta, M., and Honda, K. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3- yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther. 269:725-731, 1994.
32. Kopin, A.S., Gordon, M.C., McBride, E.W., Quinn, S.M. and Beinborn, M. Species differences in the CCK-B/gastrin receptor alter drug efficacy: Implications for preclinical testing. Regul. Pept. 64:96, 1996.
33. Dunlop, J., Brammer, N., and Ennis, C. Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human CCK-B receptor gene. Neuropeptides 30:359-363, 1996.
34. Beinborn, M., Quinn, S.M., and Kopin, A.S. Minor structural modifications of a CCK-B receptor non-peptide antagonist confer agonist or inverse agonist activity. Naunyn Schmiedebergs Arch. Pharmacol. 355:R14, 1997.
35. Hirst, G.C., Aquino, C., Birkemo, L, Croom, D.K., Dezube, M., Dougherty, R.W., Jr., Ervin, G.N., Grizzle, M.K., Henke, B., James, M.K., Johnson, M.F., Momtahen, T., Queen, K.L., Sherrill, R.G., Szewczyk, J., Willson, T.M., and Sugg, E.E., Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 2. Optimization of the C3 amino substituent. J. Med. Chem. 39:5236-5245, 1996.
36. b from inhibition curves in functional experiments: Alternatives to the Cheng-Prusoff equation. Trends Pharmacol. Sci. 14:237-239, 1993.